Gene Reports

Scope & Guideline

Bridging Research and Application in Genetics

Introduction

Welcome to your portal for understanding Gene Reports, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN-
PublisherELSEVIER
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationGENE REP / Gene Rep.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

Gene Reports focuses on advancing the understanding of genetic factors influencing health, disease, and biotechnology through various innovative methodologies.
  1. Genetic and Genomic Research:
    The journal emphasizes the exploration of genetic variations, gene expression, and their implications in health and disease, including cancer, diabetes, and genetic disorders.
  2. Molecular Biology Techniques:
    Research methods employed include next-generation sequencing, bioinformatics, and molecular cloning, which facilitate in-depth analysis of genetic materials and their functional roles.
  3. Translational Research:
    The journal bridges laboratory findings with clinical applications, aiming to translate genetic research into therapeutic strategies and diagnostic tools.
  4. Microbial and Environmental Genetics:
    There is a focus on the genetic characterization of microbial pathogens and their resistance mechanisms, reflecting the journal's commitment to public health insights.
  5. Plant and Animal Genetics:
    Research includes genetic studies in agriculture and livestock, aiming to enhance traits such as disease resistance and productivity, contributing to food security.
Gene Reports is witnessing a rise in several key research themes that reflect current scientific interests and societal needs.
  1. Cancer Genomics and Precision Medicine:
    A significant number of studies focus on the genetic underpinnings of various cancers, exploring biomarkers for diagnosis, prognosis, and tailored therapies.
  2. COVID-19 and Viral Genomics:
    Research related to SARS-CoV-2, its mutations, and the genetic factors influencing COVID-19 severity and outcomes has surged, highlighting the pandemic's impact on genetic research.
  3. MicroRNA and Non-coding RNA Research:
    The role of microRNAs and long non-coding RNAs in regulating gene expression and their implications in diseases like cancer and metabolic disorders are increasingly prevalent.
  4. Pharmacogenomics:
    Studies examining the influence of genetic variations on drug response, particularly in cancer and chronic diseases, are on the rise, reflecting a growing interest in personalized medicine.
  5. Bioinformatics and Computational Genetics:
    The application of computational tools to analyze genomic data and predict genetic associations is becoming a dominant theme, driven by the availability of large datasets.

Declining or Waning

While Gene Reports has consistently explored a range of genetic topics, some areas have shown a decline in publication frequency or interest.
  1. Traditional Genetic Studies:
    Research focused solely on classical genetics and Mendelian inheritance appears to be decreasing, as the field shifts towards more complex interactions and systems biology.
  2. Non-genomic Factors:
    Studies concentrating on environmental or epigenetic factors without a strong genetic component are less prevalent, indicating a shift towards integrative approaches that combine genetic and non-genetic factors.
  3. Basic Microbiology without Genetic Context:
    There is a waning interest in purely microbiological studies that do not incorporate genetic analyses, as the emphasis moves towards understanding microbial genetics in relation to health.

Similar Journals

NATURE REVIEWS GENETICS

Unveiling the Complexities of Genetic Science.
Publisher: NATURE PORTFOLIOISSN: 1471-0056Frequency: 12 issues/year

NATURE REVIEWS GENETICS, published by NATURE PORTFOLIO, stands as a leading journal in the field of genetics, boasting a remarkable reputation reflected in its Q1 ranking across multiple categories including Genetics, Clinical Genetics, and Molecular Biology. With an impressive percentile of 99th in both Genetics and Clinical Genetics, as well as a solid rank in Molecular Biology, this journal is pivotal for researchers, professionals, and students alike who seek to stay informed on the latest advancements and comprehensive reviews in genetic research. The journal's scope encompasses a wide array of topics, providing in-depth insights from fundamental genetic principles to clinical applications, underscoring its importance in bridging basic science and medical practice. Though not an open-access publication, it remains accessible through various academic institutions, enhancing its reach and influence within the scientific community. With publication years spanning from 2000 to 2024, NATURE REVIEWS GENETICS continues to shape the future of genetics research and education.

G3-Genes Genomes Genetics

Your Gateway to Cutting-Edge Genetic Insights
Publisher: OXFORD UNIV PRESS INCISSN: 2160-1836Frequency: 12 issues/year

G3-Genes Genomes Genetics is a prominent open access journal published by Oxford University Press, Inc., dedicated to advancing the field of genetics and genomics. Since its inception in 2011, the journal has become a vital resource for researchers, professionals, and students, featuring high-quality, peer-reviewed articles that cover a broad spectrum of topics within genetics, including clinical genetics and molecular biology. With an impressive standing reflected in its 2023 Scopus rankings, which positions it in the Q2 category for Genetics (Clinical) and Q1 for Medicine (Miscellaneous), G3 remains at the forefront of scholarly communication in these disciplines. The journal's commitment to open access ensures that cutting-edge research is accessible to a global audience, stimulating collaboration and innovation in the field. For those eager to explore the latest in genetic research, G3 serves as an indispensable platform, inviting contributions that push the boundaries of scientific understanding.

JOURNAL OF MEDICAL GENETICS

Exploring the Intersection of Genetics and Medicine.
Publisher: BMJ PUBLISHING GROUPISSN: 0022-2593Frequency: 12 issues/year

JOURNAL OF MEDICAL GENETICS, published by the BMJ PUBLISHING GROUP, stands as a premier platform in the field of genetics, focusing on both fundamental genetic research and its clinical applications. With a distinctive legacy dating back to 1965 and a significant role in advancing the understanding of genetic disorders, this journal has established itself in the top tiers with a commendable Q1 category ranking in both Genetics and Clinical Genetics as of 2023. The journal's impact is underscored by its Scopus rankings, placing it among the leading journals in the fields of medicine and genetics. Researchers and practitioners are drawn to its rigorous peer-review process and its commitment to disseminating high-quality research findings, critical reviews, and innovative clinical practices. While it is not an open-access journal, the insights provided are invaluable for anyone looking to deepen their knowledge or contribute to the burgeoning field of medical genetics.

INTERNATIONAL JOURNAL OF HUMAN GENETICS

Bridging Gaps in Human Genetic Understanding
Publisher: KAMLA-RAJ ENTERPRISESISSN: 0972-3757Frequency: 4 issues/year

INTERNATIONAL JOURNAL OF HUMAN GENETICS is a distinguished publication dedicated to advancing knowledge in the fields of genetics and molecular biology. Published by KAMLA-RAJ ENTERPRISES, this journal explores critical developments and research findings from 2008 to 2016, though its coverage in Scopus has since been discontinued. With an ISSN of 0972-3757 and an E-ISSN of 2456-6330, the journal aimed to foster scholarly dialogue and serve as a resource for researchers, professionals, and students engaged in human genetics. While the journal holds a modest ranking in categories such as Biochemistry and Genetics, it remains a vital source for exploring niche topics within the realm of human genetics. Researchers interested in genetic screening, gene therapy, and clinical genetics will find valuable insights herein. Despite its pause in indexing, the journal continues to contribute to the academic discourse by disseminating critical research that bridges gaps in understanding human genetics.

TRENDS IN GENETICS

Connecting Discoveries to the Future of Genetics
Publisher: CELL PRESSISSN: 0168-9525Frequency: 12 issues/year

TRENDS IN GENETICS, published by CELL PRESS, is a leading journal in the field of genetics, recognized for its significant impact on research and advancements in the discipline. With an impressive Scopus ranking of #10 out of 347 in the category of Genetics and a 97th percentile ranking, this journal stands as a premier platform for publishing innovative, high-quality articles that shape the future of genetic research. Since its inception in 1985, TRENDS IN GENETICS has been at the forefront of the genetic sciences, continuously disseminating crucial findings while maintaining a strong commitment to scientific rigor and integrity. Although it does not currently offer open access options, its rigorous peer-review process ensures that only the most relevant and groundbreaking studies make it to publication. Scholars and practitioners in genetics will find this journal to be an invaluable resource for keeping abreast of the latest developments, trends, and methodologies that drive the field forward.

Human Genomics

Shaping the Future of Molecular Biology and Medicine
Publisher: BMCISSN: 1473-9542Frequency: 1 issue/year

Human Genomics, published by BMC, is a leading open-access journal dedicated to advancing the field of genomics and its applications in health and disease. Since its inception in 2003, the journal has provided a vital platform for researchers to disseminate groundbreaking findings related to genetic research, contributing significantly to areas such as Drug Discovery, Genetics, Molecular Biology, and Molecular Medicine, as reflected in its Q1 and Q2 quartile rankings throughout 2023. With an ISSN of 1473-9542 and an E-ISSN of 1479-7364, Human Genomics not only delivers high-quality, peer-reviewed research but also ensures accessibility to a broader audience, empowering professionals, students, and academics to stay at the forefront of genomic science. Through its rigorous editorial standards and impactful publications, the journal fosters a collaborative environment for innovative research across the globe from its base in the United Kingdom. By promoting open access since its launch, Human Genomics continues to enhance the visibility and impact of genetic studies, making it an essential resource for anyone involved in the rapidly evolving field of human genomics.

Molecular Genetics & Genomic Medicine

Empowering the future of genomic medicine.
Publisher: WILEYISSN: 2324-9269Frequency: 12 issues/year

Molecular Genetics & Genomic Medicine, published by WILEY, is an esteemed and open-access journal that has been a prominent source of knowledge in the fields of genetics and molecular biology since its establishment in 2013. With an ISSN of 2324-9269, it aims to provide a platform for the dissemination of novel findings and innovative research that pushes the boundaries of genomics and its clinical applications. The journal holds a Q3 categorization in Genetics, Clinical Genetics, and Molecular Biology, reflecting its growing influence in these disciplines, as evidenced by its Scopus rankings. Researchers, professionals, and students alike will find valuable insights and advancements in genomic medicine, making this journal an essential resource for those dedicated to the understanding and application of genetic and molecular research in healthcare. Located at 111 River St, Hoboken, NJ, Molecular Genetics & Genomic Medicine continues to foster a global dialogue within the scientific community, ensuring accessible knowledge for all.

Microbial Cell

Unveiling the secrets of microbial interactions.
Publisher: SHARED SCIENCE PUBLISHERS OGISSN: 2311-2638Frequency: 12 issues/year

Microbial Cell is a distinguished open-access journal published by SHARED SCIENCE PUBLISHERS OG, focusing on the dynamic fields of microbiology, biochemistry, and molecular biology. Since its establishment in 2014, Microbial Cell has been at the forefront of disseminating cutting-edge research essential for advancing our understanding of microbial functions and interactions. With a commendable impact factor and ranking in the top quartiles (Q1 and Q2) across several categories, including Applied Microbiology and Biotechnology and Parasitology, this journal serves as an invaluable resource for researchers, professionals, and students alike. It features a comprehensive scope that encompasses the latest findings in genetics, cell biology, and virology, facilitating the academic community's access to high-quality peer-reviewed work. Microbial Cell not only contributes to advancing microbial sciences but also fosters an inclusive platform for knowledge sharing and collaboration in the scientific community.

Genetic Testing and Molecular Biomarkers

Exploring the Frontiers of Genomic Medicine.
Publisher: MARY ANN LIEBERT, INCISSN: 1945-0265Frequency: 12 issues/year

Genetic Testing and Molecular Biomarkers, an esteemed journal published by MARY ANN LIEBERT, INC, serves as a pivotal platform for advancing the field of genetic research and its applications in medicine. Focused on the innovative intersections of genetics and biomarker discovery, this journal has consistently contributed meaningful insights since its inception in 2009, with its scope evolving through 2024. With an ISSN of 1945-0265 and an E-ISSN of 1945-0257, it offers both traditional and open access options to cater to a broad audience of researchers, professionals, and students. Despite its current classification in the Q4 and Q3 quartiles for Genetics (clinical) and Medicine (miscellaneous) respectively, the journal remains committed to publishing high-quality, peer-reviewed articles that push the boundaries of knowledge in the field. As the landscape of genomic medicine continues to expand, Genetic Testing and Molecular Biomarkers is positioned as a crucial resource for disseminating cutting-edge discoveries and fostering interdisciplinary collaboration.

JOURNAL OF NEUROGENETICS

Unlocking the Genetic Mysteries of the Nervous System
Publisher: TAYLOR & FRANCIS LTDISSN: 0167-7063Frequency: 4 issues/year

JOURNAL OF NEUROGENETICS, published by Taylor & Francis Ltd in the United Kingdom, is an influential platform for research and discussion in the dynamic field of neurogenetics. With an ISSN of 0167-7063 and an E-ISSN of 1563-5260, this journal has been committed to advancing our understanding of the genetic underpinnings of neurological conditions since its inception in 1983. Presently categorized in the Q3 quartile for Cellular and Molecular Neuroscience and Q2 for Genetics as of 2023, it serves as an essential resource for researchers and professionals seeking insights into the genetic factors influencing nervous system function and disorder. Although it does not offer open access, the journal remains a critical repository of knowledge with a broad scope that invites contributions spanning molecular genetics to neurobiology. With its rankings in Scopus reflecting a keen focus on robust academic standards, the JOURNAL OF NEUROGENETICS is vital for those dedicated to pioneering research and finding solutions in neurogenetics, making it a significant asset to students, scholars, and industry experts alike.